**Abstract**

**Introduction:** While the high prevalence of concomitant cannabis and nicotine use in schizophrenia (SZ) has been viewed as a form of self-medication for cognitive and stress/emotional processing, the interaction of these substances has received limited study in terms of sensory/cognitive processes. The objective of this study was to assess the acute effects of nabilone (synthetic version of THC) and nicotine on the mismatch negativity (MMN) event-related potential, and to evaluate cannabinoid-nicotinic receptor interactions within a pilot study using healthy controls.

**Methods:** 20 male non-smokers and non-cannabis-users were assessed using a 5-stimulus 'optimal' multi-feature MMN paradigm within a randomized, double-blind design (placebo; nabilone \[0.5 mg\]; nicotine \[6 mg\]; and nicotine + nabilone). The MMN was quantified in the time domain and the time-frequency domain.

**Results:** The separate and combined effects of nicotine and nabilone were region- and deviant-dependent. Temporally, the MMN was impaired by nabilone and nicotine separately, whereas co-administration resulted in no impairment. Frontally, the MMN was enhanced by co-administration of nicotine and nabilone. Nabilone and the combination treatment decreased frontal evoked theta power.

**Conclusions:** It is possible that 1) cannabinoid and nicotinic receptor systems in the frontal and auditory cortex regulating sensory processes are differentially affected, and/or 2) the functional connectivity between the two MMN generators is differentially affected by the two interacting systems. Given the high prevalence rates of tobacco and cannabis use in SZ, understanding the effect of these substances and their interactions on early sensory processes underlying higher-order cognitive processes is of clinical and scientific relevance. Research supported by the Natural Sciences and Engineering Research Council of Canada (Grant \#:210572-152799-2001).
